Evaluating the Clinical Outcomes and Economic Viability of Meningococcal B Vaccination for Infants and Adolescents in the Netherlands - Top-Institutions - MDSpire

Evaluating the Clinical Outcomes and Economic Viability of Meningococcal B Vaccination for Infants and Adolescents in the Netherlands

  • By

  • Thomas Otten

  • Mirjam Knol

  • Lard Montesano Montessori

  • Pieter de Boer

  • Anneke Steens

  • February 10, 2026

  • 0 min

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Vaccine Epidemiology
    • Public Health Policy
  • #2

    National Institute for Public Health and the Environment (RIVM)
    National Institute for Public Health and the Environment (RIVM)

    Bilthoven, Netherlands

    Key Differentiators

    • Infectious Diseases
    • Vaccine Research
    • Health Economics
  • #3

    University of Oxford, Department of Paediatrics
    University of Oxford, Department of Paediatrics

    Oxford, United Kingdom

    Key Differentiators

    • Paediatric Infectious Diseases
    • Vaccine Development
    • Epidemiology
  • #4

    Institut Pasteur
    Institut Pasteur

    Paris, France

    Key Differentiators

    • Microbiology
    • Vaccine Research
    • Infectious Disease Epidemiology
  • #5

    Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public Health

    Baltimore, MD

    Key Differentiators

    • Health Economics
    • Infectious Disease Epidemiology
    • Vaccine Policy

Original Source(s)

Related Content